The role of ADAM33 in the pathogenesis of asthma

Julie A. Cakebread(University of Southampton), Stephen T. Holgate(University of Southampton), Hans Michael Haitchi(University Hospital Southampton NHS Foundation Trust), John W. Holloway(University of Southampton), Donna E. Davies(St. Mark's Hospital), Tim P. Keith(NKT Therapeutics (United States)), Robert M. Powell(Southampton General Hospital)
Springer Seminars in Immunopathology
February 1, 2004
10.1007/s00281-003-0153-z
Cited by 41

Related Papers

Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus
|The Journal of Experimental Medicine|2005|1.2k
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness
|Nature|2002|1.1k
Treatment strategies for allergy and asthma
|Nature reviews. Immunology|2008|687
Emissions from biomass burning in the Yucatan
|Atmospheric chemistry and physics|2009|590
Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma
|Clinical & Experimental Allergy|2004|520